Stephen J. Carriere, Principal Accounting Officer at Evelo Biosciences, Inc. (EVLO), sold 151 shares at $1.06 ($160) on 2023-01-23, disclosed to the SEC on 2023-01-23.
Open-market sale of $160 EVLO by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.